Benitec Biopharma Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jun 2018 | — | $13.8M | $11.9M |
| Jun 2019 | — | $16.6M | $15.7M |
| Sep 2019 | — | $17.0M | $16.6M |
| Dec 2019 | — | $15.3M | $13.8M |
| Mar 2020 | — | $12.3M | $11.4M |
| Jun 2020 | — | $10.2M | $9.8M |
| Sep 2020 | — | $7.7M | $7.5M |
| Dec 2020 | — | $14.6M | $14.0M |
| Mar 2021 | — | $10.9M | $12.0M |
| Jun 2021 | — | $20.0M | $19.8M |
| Sep 2021 | — | $15.5M | $15.7M |
| Dec 2021 | — | $10.8M | $12.3M |
| Mar 2022 | — | $7.5M | $8.6M |
| Jun 2022 | — | $2.9M | $4.1M |
| Sep 2022 | — | $14.6M | $16.5M |
| Dec 2022 | — | $9.0M | $10.5M |
| Mar 2023 | — | $4.7M | $6.6M |
| Jun 2023 | — | $202.0K | $2.5M |
| Sep 2023 | — | $22.3M | $25.9M |
| Dec 2023 | — | $15.5M | $20.4M |
| Mar 2024 | — | $11.5M | $14.1M |
| Jun 2024 | — | $47.2M | $50.9M |
| Sep 2024 | — | $64.2M | $67.8M |
| Dec 2024 | — | $75.9M | $78.3M |
| Mar 2025 | — | $97.6M | $103.6M |
| Jun 2025 | — | $97.3M | $97.7M |
| Sep 2025 | — | $93.6M | $94.5M |
| Dec 2025 | — | $187.4M | $188.8M |
| Mar 2026 | — | $183.3M | $184.8M |
| Jun 2026 | — | $177.0M | $180.0M |